2,3-Bis(bromomethyl)quinoxaline,
3138-86-1,
QUINOXALINE, 2,3-BIS(BROMOMETHYL)-,
2,3-Bis(bromomethyl)-1,4-benzodiazine,
EINECS 221-538-4,
UNII-MK7CU7QW5H,
NSC 38602,
MK7CU7QW5H,
BRN 0137771,
Benzoic acid,3-fluoro-5-nitro-,
LHKFFORGJVELPC-UHFFFAOYSA-N,
MFCD00006729,
J-640142,
C10H8Br2N2,
2,4-benzodiazine,
NSC38602,
2-hydroxybenzthiazole,
ACMC-1CQ4G,
AC1L2C2X,
2,3-Dibromomethylquinoxaline,
5-23-07-00271 (Beilstein Handbook Reference),
KSC522C3J,
SCHEMBL1258591,
DTXSID3062861,
CTK4C2134,
Quinoxaline,3-bis(bromomethyl)-,
2,3-Bis-(bromomethyl)quinoxaline,
ZINC1670799,
3379AB,
NSC-38602,
WLN: T66 BN ENJ C1E D1E,
AKOS015897202,
ACM3138861,
FCH1322654,
TRA0049579,
2,3-Bis(bromomethyl)quinoxaline, 98%,
AK122257,
CC-06783,
AX8065303,
DB-048021,
LS-142969,
TC-171405,
FT-0609498,
2,3-BIS-(BROMETHYL)-QUINOXALINE98%,
A20025,
C-30788,
I08-1095,
J-800146,
2,3-BIS QUINOXALINE,
3-fluoro-5-nitrobenzoic acid,
3-fluoro-5-nitro-benzoic Acid,
C10-H8-Br2-N2,
CID18449,
ACN-041515,
14027-75-9,